Genetic Screening and Personalized Prevention in Colorectal Cancer

4Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cancer per se is a genetic disease, either originating in germline mutations in cancer genes or in somatic mutations only present in the cancer cells. Therefore, personalized risk prediction, prevention, and treatment for cancer can be based on the results of genetic testing either in the germline or in the tumor. Surveillance regimens need to be based on appropriate risk assessment, which includes germline monogenic genetic testing - where appropriate - and in the future polygenic risk - possibly - for the general population. Treatment regimens should also include germline testing at least for cases suspicious of hereditary tumor diseases, followed by the analysis of somatic mutations within the tumor cell genome, raising a possible target for personalized therapy. Appropriate risk assessment is the key for suitable and, most importantly, individualized surveillance strategies especially in hereditary tumor syndromes. This concerns not only the patient but also the family members at risk. An overview about the different fields and aspects of genetic testing in colorectal cancer and its impact on personalized prevention will be given below.

References Powered by Scopus

PD-1 blockade in tumors with mismatch-repair deficiency

7533Citations
N/AReaders
Get full text
2727Citations
N/AReaders
Get full text

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

2709Citations
N/AReaders
Get full text

Cited by Powered by Scopus

BMP-9 is a novel marker for colorectal tumorigenesis undergoing the normal mucosa-adenoma-adenocarcinoma sequence and is associated with colorectal cancer prognosis

13Citations
N/AReaders
Get full text

DERL3 suppresses colorectal cancer metastasis through negatively regulating MYcn level

4Citations
N/AReaders
Get full text

The role of genetic data analysis for precision therapy in cancer: Personalized medicine concept in cancer treatment

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Steinke-Lange, V., & Holinski-Feder, E. (2019, August 1). Genetic Screening and Personalized Prevention in Colorectal Cancer. Visceral Medicine. S. Karger AG. https://doi.org/10.1159/000501941

Readers' Seniority

Tooltip

Researcher 4

80%

PhD / Post grad / Masters / Doc 1

20%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 3

50%

Medicine and Dentistry 2

33%

Business, Management and Accounting 1

17%

Save time finding and organizing research with Mendeley

Sign up for free